key: cord-0446651-7wjd8krv
authors: Rodr'iguez, Jorge P.; Egu'iluz, V'ictor M.
title: Coupling between COVID-19 and seasonal influenza leads to synchronization of their dynamics
date: 2020-09-17
journal: nan
DOI: nan
sha: 6361339942e52ed091d243a4c30b4902f6472314
doc_id: 446651
cord_uid: 7wjd8krv

Interactions between COVID-19 and other pathogens may change their dynamics. Specifically, this may hinder the modelling of empirical data when the symptoms of both infections are hard to distinguish. We introduce a model coupling the dynamics of COVID-19 and seasonal influenza, simulating cooperation, competition and asymmetric interactions. We find that the coupling synchronizes both infections, with a strong influence on the dynamics of influenza, reducing its time extent to a half.

We model the interaction between the spreading processes of COVID-19 and seasonal influenza. The independent COVID-19 infection is modelled as a SEIR (Susceptible-Exposed-Infected-Recovered) dynamics, such that susceptible individuals in contact with infected individuals become exposed with a rate β c , spontaneously become infected with a rate 1/τ Ec and recover from the infected state with a rate 1/τ c . The dynamics of independently spreading influenza is described by the SIR (Susceptible-Infected-Recovered) model, analogous to that of COVID-19 but without the exposed state, with an infection rate β i and a recovery rate 1/τ i . We consider the deterministic mean-field equations describing these processes, extracting the parameters from the literature (Table I, [7, 8] ). The interaction implies that individuals that are not susceptible to COVID-19 (influenza) become infected with influenza (COVID-19) with a rate k i β i (k c β c ) (Fig. 1) . Values of k i and k c higher than 1 represent a cooperative interaction (known as co-infection), while values that are lower than 1 describe competitive interactions, typically introduced as cross-immunity, although this can also illustrate the non-pharmaceutical intervention of keeping infected individuals in quarantine and, hence, isolating them from the other pathogen.

The dynamics describing the temporal evolution of the 12 states introduced in Fig. 1 

We numerically integrate the equations describing this dynamics, starting from the initial condition s(t=0) = 1−ϵ, q c (t = 0) = t c (t = 0) = q i (t = 0) = t i (t = 0) = ϵ/2, e c (t = 0) = f c (t = 0) = f i (t = 0) = 0, with ϵ = 0.01.

First, we analyse the non-interacting scenario (k i = k c = 1), observing that the dynamics of COVID-19 reaches a higher peak before the peak of influenza (Fig. 2) . Specifically, it takes influenza twice the time that it takes COVID-19 to reach its peak, with the prevalence at the peak of COVID-19 being 5 times higher than that displayed at the peak of influenza. We observe that, under this mean-field dynamics, the COVID-19 reaches all the population along with this infection wave (cumulative prevalence f c higher than 98%), while influenza reaches a cumulative prevalence f i of 44% (see Supplementary Text 1, Fig. 2 inset), such that under the mean-field well-mixed assumption, the cumulative prevalence of people with both infections approaches f i . The simplification of our model of 12 states into a set of 8 differential equations does not allow us to isolate the number of individuals affected by at least one active infection, but we approximate it by Q = q c + q i , which is a maximum bound of it and a good estimator as far as [I c I i ] is low. This parameter reaches its peak close to the peak of COVID-19, and displays a long tail due to the slower spreading of influenza (Fig. 2) .

In the interactive scenarios, the COVID-19 infection dominates the dynamics, and its prevalence curve does not change considerably due to the interactions, but it influences that of influenza (Fig. 3) . Specifically, when the interaction is competitive for the infection of COVID-19 (k c < 1), the time at which the maximum prevalence of COVID-19 is reached does not significantly change (variations smaller than 0.2 days), and it has a slightly lower prevalence (relative decrease in 2% of k i =0.5 and 4% for k i =2, Fig. 3a ,b), with the opposite behaviour for cooperative infections (relative increase in 2% for k i =0.5 and 3% for k i =2, Fig. 3c ,d), but without experiencing major changes in the peak prevalence. In contrast, competitive interactions in the influenza infection (k i < 1) considerably reduce the peak (relative decrease in 68% for both k c =0.5 and k c =2) and the time taken to reach it (from 41.60 days to 15.40 and 15.15 days for k c =0.5 and k c =2, respectively, Fig. 3a,c) , because as the COVID-19 infection initially grows faster than the influenza infection, the competitive interaction flattens the prevalence curve of influenza. The cooperative interaction for influenza infection (k i > 1) also reduces the time taken to reach its maximum prevalence (28.91 and 28.68 days for k c =0.5 and k c =2, respectively) but increases the height of this peak (relative increases in 500% and 509% for k c =0.5 and k c =2, respectively, Fig. 3b ,d). When we consider the variable Q = q c + q i , which is a good estimator of the demand in the health care centres, we realize that first, the temporal extent of the dynamics is halved, from approximately 100 to 50 days, and that this demand is affected by k i , such that k i = 0.5 slightly reduces the peak demand and k i = 2 increases it in a factor 1.5 (Fig. 3 insets) .

Interaction between the infections of COVID-19 and influenza is translated into a synchronization of their temporal behaviours, driven by the COVID-19 infection, which initially grows faster (Fig. 2) . We explore the prevalence at the peaks q M and their arrival times T M in two cases: an asymmetric interaction (k c = 1, k i variable), and a symmetric interaction (k c = k i variable). In the asymmetric scenario, any interaction (k i > 1), decreases the arrival time of the influenza peak (Fig. 4a) . Interestingly, this interaction makes the prevalence of influenza higher than that of COVID-19, and it reaches a maximum for k i = 5.8, with also the influenza peak arriving earlier than that of COVID-19, such that the influenza prevalence curve could be interpreted as an early-warning of the COVID-19 curve, arriving later due to the exposure period. In the symmetric interaction, we find a similar behaviour for influenza, while COVID-19 does not substantially modify the arrival time of its peak, and there is more variation on its peak intensity, even if the change of values is much lower than the observed for influenza (Fig. 4b) . We observe an optimal value for the interaction parameter k i in both cases such that the peak of influenza displays a maximum prevalence, interpreted as a resonance between both infection processes, such that if k i is higher, the peak of influenza will occur earlier, but in a moment where the fraction of exposed individuals to COVID-19 is not maximum yet.

Mathematical modelling of infectious diseases is becoming a fundamental tool for forecasting and policy-making, leading to a remarkable effort for revealing the statistical properties of the models of spreading dynamics [9] . In fact, the interaction between multiple infections represents an additional degree of complexity. Our model illustrates the interaction between two infections described by different dynamics in their independent spread. We recognize that this work has some limitations. First, it considers a mean-field dynamics without focusing on the interaction network, with details leading to a rich dynamics in the frame of interactive infections in static complex networks [10] or temporal networks [11] . Additionally, we consider that the interaction modifies the infection rates, while an extended model would include the effects of the interaction in recovery rates, as observations reflect that coinfection of SARS-CoV-2 and other pathogens leads to longer lengths of the hospitalary stays [12] .

Research on the interactions of COVID-19 with other infections is still ongoing. Indeed, the competitive process due to the cross-immunity is controversial, as the immune system displays different response pathways to COVID-19 and influenza [13] , in contrast to recent reports that revealed that T cells related to the immune response to common cold coronaviruses react against SARS-CoV-2 [14, 15] . Regarding coinfection of SARS-CoV-2 and other respiratory pathogens, empirical observations reported a reduced frequency of other pathogens in individuals that were tested positive for SARS-CoV-2 (20.7%) in contrast to the frequency in those tested negative (26.7%) [16] , while other observations reported even lower frequencies of other respiratory pathogens, represented by 2.99% for individuals tested positive and 13.1% for individuals tested negative [17] .

Apart from the biomedical interpretation of the interactions, our well-mixed framework may include the effects of non-pharmaceutical interventions, leading to a reduced prevalence of other diseases, such as influenza, due to the preventive lockdown against the spreading of COVID-19 [18, 19] , the slowing down of vaccination campaigns against other infections, thus facilitating their spread [20] , or the disruption on treatment and preventive actions against HIV [21] .

We have shown a synchronization process between COVID-19 and influenza. In fact, correlations between the empirical number of positive-tested patients of COVID-19 and excess influenza-like illness cases have been reported [22, 23] , which could emerge either from considering non-positive COVID-19 patients within those cases or from the synchronization between COVID-19 and influenza-like illness outbreaks. Our results reveal how the prevalence information from other infections may inform us about the evolution of COVID-19 outbreaks and, at the same time, facilitate the inference of the prevalence curve when the reporting managers are not able to distinguish between the symptoms of the considered interacting infections.

Infection rate (days -1 )

Ref.

COVID-19 β c = 1.12 τ Ec = 3.69 τ c = 3.47 [7] Seasonal influenza β i = 0.32 x τ i = 4.1 [8] Table I. Parameters extracted from the literature for the dynamics of COVID-19 and seasonal influenza. Fig. 1 . Scheme of the dynamics. The letters inside the circles denote the 12 possible states in the SEIR-SIR dynamics, the letters over the arrows represent the transition rates between the states, and the arrow colors depict the exposure to other states necessary for each transition, with black, orange and blue colors representing, respectively, spontaneous processes, processes under the exposure to the COVID-19 infected population, and processes under the exposure to the population infected with influenza. Solving numerically this equation with the parameters s 0 = 1− ϵ/2, ϵ = 0.01, β = 0.32 and τ = 4.1, we obtain r(t → ∞) ≈ 0.445.

Considering a SIR model, with the evolution described in Supplementary Text 1, the maximum value of the fraction of infected is obtained imposing di/dt = 0, which leads to s p = 1/βτ, where the subindex p indicates the value at the peak. Considering s(t) = s 0 e −βτ r(t) and s p + i p + r p = 1, we obtain i p = 1 −1/R(1 + log s 0 /R), where R = 1/βτ is the basic reproductive number.

Substituting s 0 = 1 − ϵ/2, with ϵ = 0.01 and the parameters detailed in Table I , we obtain i p ≈ 0.0346.

Dynamics of interacting diseases

Outbreaks of coinfections: The critical role of cooperativity

Leprosy and tuberculosis: the epidemiological consequences of cross-immunity

Tuberculosis and HIV co-infection

Epidemiology of viral hepatitis and hiv co-infection

Co-infection with zika and dengue viruses in 2 patients

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Seasonal influenza in the United States, France, and Australia: transmission and prospects for control

Epidemic processes in complex networks

Avalanche outbreaks emerging in cooperative contagions

Particle velocity controls phase transitions in contagion dynamics

The microbial coinfection in COVID-19

Single-cell sequencing of peripheral blood mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans

SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19

Rates of coinfection between SARS-CoV-2 and other respiratory pathogens

Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus?

Monitoring respiratory infections in COVID-19 epidemics

How will COVID-19 affect the coming flu season? Scientists struggle for clues

Pandemic brings mass vaccinations to a halt

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models

Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France

Using influenza surveillance networks to estimate state-specific prevalence of SARS-CoV-2 in the United States